Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Does current evidence justify prostate cancer screening in Europe?

Literature DB >> 16270078

Does current evidence justify prostate cancer screening in Europe?

Richard M Martin¹, George Davey Smith, Jenny Donovan.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 2005 PMID： 16270078 PMCID： PMC2764233 DOI： 10.1038/ncponc0349

Source DB: PubMed Journal: Nat Clin Pract Oncol ISSN： 1743-4254

× No keyword cloud information.

12 in total

1. Comparison of trends in prostate-cancer mortality in England and Wales and the USA.

Authors: S E Oliver; D Gunnell; J L Donovan
Journal: Lancet Date: 2000-05-20 Impact factor: 79.321

2. Natural experiment examining impact of aggressive screening and treatment on prostate cancer mortality in two fixed cohorts from Seattle area and Connecticut.

Authors: Grace Lu-Yao; Peter C Albertsen; Janet L Stanford; Therese A Stukel; Elizabeth S Walker-Corkery; Michael J Barry
Journal: BMJ Date: 2002-10-05

3. Screening for prostate cancer: estimating the magnitude of overdetection.

Authors: M McGregor; J A Hanley; J F Boivin; R G McLean
Journal: CMAJ Date: 1998-12-01 Impact factor: 8.262

4. Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower.

Authors: Ian M Thompson; Donna Pauler Ankerst; Chen Chi; M Scott Lucia; Phyllis J Goodman; John J Crowley; Howard L Parnes; Charles A Coltman
Journal: JAMA Date: 2005-07-06 Impact factor: 56.272

5. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study.

Authors: J L Stanford; Z Feng; A S Hamilton; F D Gilliland; R A Stephenson; J W Eley; P C Albertsen; L C Harlan; A L Potosky
Journal: JAMA Date: 2000-01-19 Impact factor: 56.272

Review 6. Screening for prostate cancer.

Authors: Stephen Frankel; George Davey Smith; Jenny Donovan; David Neal
Journal: Lancet Date: 2003-03-29 Impact factor: 79.321

7. Validity of the prostate specific antigen test for prostate cancer screening: followup study with a bank of 21,000 sera in Finland.

Authors: M Hakama; U H Stenman; A Aromaa; J Leinonen; T Hakulinen; P Knekt
Journal: J Urol Date: 2001-12 Impact factor: 7.450

8. The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years?

Authors: Thomas A Stamey; Mitchell Caldwell; John E McNeal; Rosalie Nolley; Marci Hemenez; Joshua Downs
Journal: J Urol Date: 2004-10 Impact factor: 7.450

9. Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter.

Authors: Ian M Thompson; Donna K Pauler; Phyllis J Goodman; Catherine M Tangen; M Scott Lucia; Howard L Parnes; Lori M Minasian; Leslie G Ford; Scott M Lippman; E David Crawford; John J Crowley; Charles A Coltman
Journal: N Engl J Med Date: 2004-05-27 Impact factor: 91.245